Perturbation of the gut microbiome and association with outcomes following autologous stem cell transplantation in patients with multiple myeloma

References

• Attal M, Lauwers-Cances V, Hulin C, et al. Lenalidomide, bortezomib, and dexamethasone with transplantation for myeloma. N Engl J Med. 2017;376(14):1311–1320.
   PubMed Web of Science ®Google Scholar
• Kumar S, Mahmood ST, Lacy MQ, et al. Impact of early relapse after auto-SCT for multiple myeloma. Bone Marrow Transplant. 2008;42(6):413–420.
   PubMed Web of Science ®Google Scholar
• Lynch SV, Pedersen O. The human intestinal microbiome in health and disease. N Engl J Med. 2016;375(24):2369–2379.
   PubMed Web of Science ®Google Scholar
• D’Angelo CR, Sudakaran S, Callander NS. Clinical effects and applications of the gut microbiome in hematologic malignancies. Cancer. 2021;127(5):679–687.
   PubMed Web of Science ®Google Scholar
• Andermann TM, Peled JU, Ho C, Blood and Marrow Transplant Clinical Trials Network, et al. The microbiome and hematopoietic cell transplantation: past, present, and future. Biol Blood Marrow Transplant. 2018;24(7):1322–1340.
   PubMed Web of Science ®Google Scholar
• Taur Y, Jenq RR, Perales MA, et al. The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation. Blood. 2014;124(7):1174–1182.
   PubMed Web of Science ®Google Scholar
• Peled JU, Devlin SM, Staffas A, et al. Intestinal microbiota and relapse after hematopoietic-cell transplantation. J Clin Oncol. 2017 May 20;35(15):1650–1659.
   PubMed Web of Science ®Google Scholar
• Peled JU, Gomes ALC, Devlin SM, et al. Microbiota as predictor of mortality in allogeneic hematopoietic-cell transplantation. N Engl J Med. 2020;382(9):822–834.
   PubMed Web of Science ®Google Scholar
• Pianko MJ, Devlin SM, Littmann ER, et al. Minimal residual disease negativity in multiple myeloma is associated with intestinal microbiota composition. Blood Adv. 2019 Jul 9;3(13):2040–2044.
   PubMed Web of Science ®Google Scholar
• Khan N, Lindner S, Gomes AL, et al. Fecal microbiota diversity disruption and clinical outcomes after auto-HCT: a multicenter observational study. Blood;137(11):1527-1537. 2020.
   Google Scholar
• El Jurdi N, Filali-Mouhim A, Salem I, et al. Gastrointestinal microbiome and mycobiome changes during autologous transplantation for multiple myeloma: results of a prospective pilot study. Biol Blood Marrow Transplant. 2019;25(8):1511–1519.
   PubMed Web of Science ®Google Scholar
• Bansal R, Park H, Taborda CC, et al. Antibiotic exposure, not alloreactivity, is the major driver of microbiome changes in hematopoietic cell transplantation. Transplant Cell Ther. 2022;28(3):135–144.
   PubMedGoogle Scholar
• Viaud S, Saccheri F, Mignot G, et al. The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide. Science. 2013;342(6161):971–976.
   PubMed Web of Science ®Google Scholar
• Calcinotto A, Brevi A, Chesi M, et al. Microbiota-driven interleukin-17-producing cells and eosinophils synergize to accelerate multiple myeloma progression. Nat Commun. 2018;9(1):4832.
   PubMedGoogle Scholar
• Jian X, Zhu Y, Ouyang J, et al. Alterations of gut microbiome accelerate multiple myeloma progression by increasing the relative abundances of nitrogen-recycling bacteria. Microbiome. 2020;8(1):74.
   PubMed Web of Science ®Google Scholar
• Claesson MJ, Jeffery IB, Conde S, et al. Gut microbiota composition correlates with diet and health in the elderly. Nature. 2012;488(7410):178–184.
   PubMed Web of Science ®Google Scholar
• National Institutes of Health EaGRP. Diet History Questionnaire Version 3.0. National Cancer Institute. 2010.
   Google Scholar
• Kumar S, Paiva B, Anderson KC, et al. International myeloma working group consensus criteria for response and minimal residual disease assessment in multiple myeloma. Lancet Oncol. 2016;17(8):e328–e346.
   PubMed Web of Science ®Google Scholar
• Flores-Montero J, Sanoja-Flores L, Paiva B, et al. Next generation flow for highly sensitive and standardized detection of minimal residual disease in multiple myeloma. Leukemia. 2017;31(10):2094–2103.
   PubMed Web of Science ®Google Scholar
• Eggers S, Malecki KM, Peppard P, et al. Wisconsin microbiome study, a cross-sectional investigation of dietary fibre, microbiome composition and antibiotic-resistant organisms: rationale and methods. BMJ Open. 2018;8(3):e019450.
   PubMed Web of Science ®Google Scholar
• Kozich JJ, Westcott SL, Baxter NT, et al. Development of a dual-index sequencing strategy and curation pipeline for analyzing amplicon sequence data on the MiSeq illumina sequencing platform. Appl Environ Microbiol. 2013;79(17):5112–5120.
   PubMed Web of Science ®Google Scholar
• Bolyen E, Rideout JR, Dillon MR, et al. Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2. Nat Biotechnol. 2019;37(8):852–857.
   PubMed Web of Science ®Google Scholar
• Callahan BJ, McMurdie PJ, Rosen MJ, et al. DADA2: high-resolution sample inference from illumina amplicon data. Nat Methods. 2016;13(7):581–583.
   PubMed Web of Science ®Google Scholar
• Katoh K, Standley DM. MAFFT multiple sequence alignment software version 7: improvements in performance and usability. Mol Biol Evol. 2013;30(4):772–780.
   PubMed Web of Science ®Google Scholar
• Price MN, Dehal PS, Arkin AP. FastTree 2–approximately maximum-likelihood trees for large alignments. PLoS One. 2010;5(3):e9490.
   PubMed Web of Science ®Google Scholar
• Abraham A, Pedregosa F, Eickenberg M, et al. Machine learning for neuroimaging with scikit-learn. Front Neuroinform. 2014;8(14):14.
   PubMedGoogle Scholar
• Agriculture USDoHaHSaUSDo. 2015-2020 Dietary Guidelines for Americans. 2020. 12/2015;8.
   Google Scholar
• Institute NC. The Healthy Eating Index- Population Ratio Method. 2017.
   Google Scholar
• Segata N, Izard J, Waldron L, et al. Metagenomic biomarker discovery and explanation. Genome Biol. 2011;12(6):R60.
   PubMed Web of Science ®Google Scholar
• Hwang SR, Higgins A, Castillo Almeida NE, et al. Effect of antibiotic use on outcomes in patients with hodgkin lymphoma treated with immune checkpoint inhibitors. Leuk Lymphoma. 2021;62(1):247–251.
   PubMed Web of Science ®Google Scholar
• Routy B, Le Chatelier E, Derosa L, et al. Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors. Science. 2018;359(6371):91–97.
   PubMed Web of Science ®Google Scholar
• Jenq RR, Taur Y, Devlin SM, et al. Intestinal blautia is associated with reduced death from graft-versus-Host disease. Biol Blood Marrow Transplant. 2015;21(8):1373–1383.
   PubMed Web of Science ®Google Scholar
• Smith ML, Slingerland J, Clurman A, et al. Intestinal microbiome analyses identify biomarkers for patient response to CAR T cell therapy [conference abstract. Biol Blood Marrow Transplant. 2019;25(3):S177.
   Web of Science ®Google Scholar
• Routy B, Gopalakrishnan V, Daillere R, et al. The gut microbiota influences anticancer immunosurveillance and general health. Nat Rev Clin Oncol. 2018;15(6):382–396.
   PubMed Web of Science ®Google Scholar
• Iida N, Dzutsev A, Stewart CA, et al. Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment. Science. 2013;342(6161):967–970.
   PubMed Web of Science ®Google Scholar
• Paulos CM, Wrzesinski C, Kaiser A, et al. Microbial translocation augments the function of adoptively transferred self/tumor-specific CD8+ T cells via TLR4 signaling. J Clin Invest. 2007;117(8):2197–2204.
   PubMed Web of Science ®Google Scholar
• Sivan A, Corrales L, Hubert N, et al. Commensal bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy. Science. 2015;350(6264):1084–1089.
   PubMed Web of Science ®Google Scholar
• Malik MA, Sweeney NW, Jafri M, et al. Nutrition perceptions, needs and practices among patients with plasma cell disorders. Blood Cancer J. 2022;12(4):70.
   PubMed Web of Science ®Google Scholar
• Ubago-Guisado E, Rodriguez-Barranco M, Ching-Lopez A, et al. Evidence update on the relationship between diet and the most common cancers from the European Prospective Investigation into cancer and nutrition (EPIC) study: a systematic review. Nutrients. 2021;13(10):3582.
   PubMed Web of Science ®Google Scholar
• Thordardottir M, Lindqvist EK, Lund SH, et al. Dietary intake is associated with risk of multiple myeloma and its precursor disease. PLoS One. 2018;13(11):e0206047.
   PubMed Web of Science ®Google Scholar
• Cronin P, Joyce SA, O’Toole PW, et al. Dietary fibre modulates the gut microbiota. Nutrients. 2021;13(5):1655.
   PubMed Web of Science ®Google Scholar
• Jefferson A, Adolphus K. The effects of intact cereal grain fibers, including wheat bran on the gut microbiota composition of healthy adults: a systematic review. Front Nutr. 2019;6:33.
   PubMed Web of Science ®Google Scholar